# Monita Mo

> Monita Mo is a Series A investor at Ascend Capital Partners backing Medical and Lighting. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Ascend Capital Partners](https://shizune.co/investors/profile/ascend-capital-partners-6051)
- Location: New City, United States
- Total investments: 2
- Last investment: Feb 2018
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/monita-mo-354a703/

Monita Mo is a Series A investor at Ascend Capital Partners in New City focused on Medical and Lighting. Monita Mo - CEO @ Ascend Capital Partners

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 50% |
| Lighting | 1 | 50% |
| Software | 1 | 50% |
| Education | 1 | 50% |
| Automotive | 1 | 50% |

16 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 50% |
| Series B | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| TactoTek | TactoTek develops and licenses injection-molded structural electronics (IMSE®) technologies. Automotive, aviation, connected home, industrial control, and medical brands use TactoTek innovations to create next-generation user experiences that are compelling, differentiated, and more sustainable. Designers use TactoTek IP to integrate circuits andcomponents directly into plastic parts, transforming conventional structures into smart interactive surfaces. TactoTek licenses its intellectual property, including over 280 patents and critical know-how developed over a decade of intensive R&D and quality testing, to global manufacturers who use reliable, standardized manufacturing processes to produce curved-shape and conformal electronics | $14.6M | Series B | Feb 15, 2018 |  |
| Aiforia | Aiforia Technologies was founded as a spin-off company from the Finnish Institute for Molecular Medicine (FIMM) at the University of Helsinki in 2013 by researchers and pioneers in the field of cloud-based microscopy and pathology and experienced life science entrepreneurs. The Aiforia® Platform brings together deep learning AI and high-performancecloud computing. Aiforia assists with the increased demand for image-based diagnostics by providing efficient and scalable solutions – enabling new discoveries and clinical support with highly accurate and consistent data. Aiforia is technologically driven establishment and keeps the capability of being image agnostic thus extending its solutions to multiple fields. | $5.5M | Series A | Dec 01, 2017 |  |

2 of 2 investments shown.

## Co-investors
- [Conor Venture Partners](https://shizune.co/investors/profile/conor-venture-partners) — VC Fund, 1 deal together
- [Forvia](https://shizune.co/investors/profile/faurecia-sa) — VC Fund, 1 deal together

## About Ascend Capital Partners

VC Fund · Hong Kong, Hong Kong

Founded by two Wall Street professionals in 2002 with the goal of making companies successful by helping them raise capital and improve their management standards. This was done by taking an active role in running these companies (at the Board level and operationally) and helping to secure strategic partnerships.Over USD 100 million in assetsgenerated from successful investments in China, and more recently in Europe. All invested funds come from our partners; no 3rd party money is managed. Since the partners are investing their own capital, they are dedicated to making their investments successful.Led by Monita Mo, one of the founders and a serial entrepreneur. Our partners have decades of experience across a wide range of industries and geographical regions. All investment partners have done business in Asia and bring an extensive network of contacts for our investments. Additionally, they have started, managed, and sold businesses and understand the challenges involved.See the need to share more developed technology to other markets, especially in China, where growth opportunities may be greater. That is why we are currently focusing on companies in Europe and other developed markets that have unique technologies that can be commercialized in their home markets, Asia, and the US.

1 contacts available at Ascend Capital Partners.

| Name | Title | Profile |
| --- | --- | --- |
| Monita Mo | CEO | https://shizune.co/investors/profile/monita-mo |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Monita Mo invest in?

Monita Mo invests primarily in Medical, Lighting and Software startups, most often at Series A and Series B stage. Most of the 2 investments tracked by Shizune back companies in Finland. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Monita Mo last invest?

The most recent investment recorded for Monita Mo closed in Feb 2018. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co